FABP4 and hepatocellular carcinoma: Notably, serum FABP4 levels positively correlated with BMI in MASLD-HCC patients (Pearson’s r = 0.4467), while the correlation was weak in HBV-induced HCC patients (Pearson’s r = 0.0701).